US Patent Issued to DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION on Dec. 23 for "Compound comprising EZH2 inhibitor and E3 ligase binder and pharmaceutical composition for preventing or treating EZH2-associated disease comprising same as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,434, issued on Dec. 23, was assigned to DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (Daegu, South Korea).

"Compound comprising EZH2 inhibitor and E3 ligase binder and pharmaceutical composition for preventing or treating EZH2-associated disease comprising same as active ingredient" was invented by Ji-Hoon Yu (Daegu, South Korea), Chun Young Im (Daegu, South Korea), So Young Kim (Daegu, South Korea), Ye Ri Han (Daegu, South Korea), Doohyun Lee (Daegu, South Korea), Hui-Jeon Jeon (Daegu, South Korea), Sang-Hyun Min (Daegu, South Korea), Bae Jun Oh (Daegu, South Korea), Sang-Wook Park (Daegu, South Korea), Dong-Kyu Choi (Daegu, South Korea), Young-Kyu Kim (Daegu, South Korea), Sung...